Mark Deguenther
Urology · Homewood, ALNPI 1609849488
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.0%), consulting fees and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Boston Scientific at 32.5% of the total. Reporting peaked in 2020 at $1,197 and has fallen 97.6% since, to $28 in 2023. That places this record below the midpoint for urology clinicians in AL, where the typical reported total is $3,591.
Across 89 payments — averaging $28.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$823
- Astellas Pharma US Inc$207
- Baxter Healthcare$186
- AbbVie$174
- Endo Pharmaceuticals Inc.$149
- Urogen Pharma, Inc.$133
- plus $861 from 21 others
Across 171 payments — averaging $1985.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$149K
- Astellas Pharma Global Development$145K
- Eli Lilly$25K
- Janssen Research & Development, LLC$15K
- Procept Biorobotics Corporation$5K
What the payments were for
- Consulting fees$80032%
- Food & beverage$1,39355%
- Education$34013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $823 |
| Astellas Pharma US Inc | 9 | $207 |
| Baxter Healthcare | 3 | $186 |
| AbbVie(2 entities) | 5 | $174 |
| Endo Pharmaceuticals Inc. | 8 | $149 |
| Urogen Pharma, Inc. | 8 | $133 |
| Urovant Sciences Inc | 7 | $120 |
| Medtronic(2 entities) | 4 | $102 |
| Johnson & Johnson | 1 | $79 |
| Abbott | 3 | $51 |
| Travere Therapeutics, Inc. | 16 | $49 |
| Myovant Sciences Inc. | 3 | $48 |
| Myriad Genetic Laboratories, Inc. | 2 | $47 |
| Tolmar Pharmaceuticals, Inc. | 2 | $41 |
| Dendreon Pharmaceuticals LLC | 2 | $37 |
| Progenics Pharmaceuticals, Inc. | 1 | $34 |
| Neotract Inc. | 1 | $32 |
| Aytu Biopharma, Inc. | 2 | $31 |
| Coloplast | 2 | $30 |
| 180 Medical, Inc. | 1 | $29 |
| Blue Earth Diagnostics | 1 | $24 |
| Merck | 1 | $24 |
| Pfizer | 1 | $19 |
| Convatec Inc. | 1 | $19 |
| Mckesson Patient Care Solutions Inc. | 1 | $17 |
| Metuchen Pharmaceuticals | 1 | $14 |
| Axonics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,533 in reported general payments places this provider in the 40th percentile of 179 urology providers in Alabama.
Other urology in Homewood
- Brian ChristineHomewood$215K
- Vincent BivinsHomewood$117K
- Rachel EngelbergHomewood$61K
- Rupa KitchensHomewood$14K
- Jared CoxHomewood$12K
- Brian WadeHomewood$9K
- Donald BraggHomewood$8K
- Tyler PostonHomewood$6K
- Paula RookisHomewood$6K
- Leon HamrickHomewood$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.